RSS

Promacta

The US Food and Drug Association (FDA) expands use of Novartis drug Promacta to include treatment of children ages one and older with chronic immune thrombocytopenia (ITP) more

News

FDA approves sNDA for eltrombopag in patients with severe aplastic anaemia who have had an insufficient response to immunosuppressive therapy. more